New Nordic Healthbrands AB (SE:NNH)

:NNH

NNH

New Nordic Healthbrands AB

RESEARCH TOOLSreports

New Nordic Healthbrands AB (NNH) Price & Analysis

0 Followers

NNH Stock Chart & Stats

kr21.50

kr0.00(0.00%)

At close: Mar 05 4:00 PM EST

kr21.50

kr0.00(0.00%)

Day’s Range― - ―

52-Week Rangekr13.20 - kr28.00

Previous CloseN/A

Volume5.00K

Average Volume (3M)5.45K

Market Cap

kr109.04M

Enterprise Valuekr128.33M

Total Cash (Recent Filing)kr16.55M

Total Debt (Recent Filing)kr35.84M

Price to Earnings (P/E)17.5

Beta0.14

Next Earnings

Apr 29, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.33

Shares Outstanding6,195,200

10 Day Avg. Volume3,153

30 Day Avg. Volume5,451

Financial Highlights & Ratios

PEG Ratio-0.08

Price to Book (P/B)1.39

Price to Sales (P/S)0.25

P/FCF Ratio18.98

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthA pronounced 16.9% revenue jump in 2025 indicates durable demand expansion or successful market initiatives. Sustained top-line growth improves the company's ability to invest in brand, product development and distribution, supporting long-term scale and competitive positioning versus peers.

Improving Capital StructureLower leverage and a return to positive ROE signal improving financial resilience and optionality. A more conservative balance sheet reduces refinancing risk, supports investment or M&A flexibility, and increases the firm's capacity to withstand cyclical headwinds over the medium term.

Strong Cash Conversion In 2025High free-cash-flow-to-profit conversion (~90% in 2025) demonstrates the company can turn reported earnings into usable cash when conditions are favorable. Reliable cash conversion underpins self-funded growth, capex, and potential shareholder returns over multiple quarters.

Bears Say

Gross Margin PressureA material decline in gross margin suggests either rising input costs, unfavorable product mix, or reported accounting changes. If persistent, margin erosion compresses operating profitability and limits the firm's ability to fund marketing, R&D or pricing flexibility, weakening long-term competitiveness.

Inconsistent Cash GenerationMulti-year swings between negative and positive cash flow point to uneven working-capital management and volatile cash generation. This unpredictability makes planning and funding growth harder, may force external financing during down cycles, and raises execution risk over months.

Fragile ProfitabilityA thin 1.4% net margin after multiple years of losses indicates earnings are fragile and subject to reversal. Low profitability leaves limited buffer for cost shocks or investment needs, raising the probability that future shocks could return the company to loss-making territory.

NNH FAQ

What was New Nordic Healthbrands AB’s price range in the past 12 months?

New Nordic Healthbrands AB lowest stock price was kr13.20 and its highest was kr28.00 in the past 12 months.

What is New Nordic Healthbrands AB’s market cap?

New Nordic Healthbrands AB’s market cap is kr109.04M.

When is New Nordic Healthbrands AB’s upcoming earnings report date?

New Nordic Healthbrands AB’s upcoming earnings report date is Apr 29, 2026 which is in 26 days.

How were New Nordic Healthbrands AB’s earnings last quarter?

New Nordic Healthbrands AB released its earnings results on Feb 28, 2026. The company reported kr0.329 earnings per share for the quarter, beating the consensus estimate of N/A by kr0.329.

Is New Nordic Healthbrands AB overvalued?

According to Wall Street analysts New Nordic Healthbrands AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does New Nordic Healthbrands AB pay dividends?

New Nordic Healthbrands AB pays a Annually dividend of kr1.25 which represents an annual dividend yield of N/A. See more information on New Nordic Healthbrands AB dividends here

What is New Nordic Healthbrands AB’s EPS estimate?

New Nordic Healthbrands AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does New Nordic Healthbrands AB have?

New Nordic Healthbrands AB has 6,195,200 shares outstanding.

What happened to New Nordic Healthbrands AB’s price movement after its last earnings report?

New Nordic Healthbrands AB reported an EPS of kr0.329 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.398%.

Which hedge fund is a major shareholder of New Nordic Healthbrands AB?

Currently, no hedge funds are holding shares in SE:NNH

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

New Nordic Healthbrands AB

New Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden. The company provides vitality products for immune system. The company provides balm, repair mask, shampoo, shine serum, chewing gum, face and eye cream, and dietary supplements. It offers its products under Hair Volume, Skin Care, Beauty In & Out, and New Nordic brand names. The company sells its products through pharmacies, department stores, health stores, travel retailers, and beauty shops, as well as through online stores in 41 countries in North America, Canada, Europe, the United States, and internationally. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.